NCT02666703View on ClinicalTrials.gov

Extracorporeal Cytokine Adsorption in Cardiac Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

June 30, 2018

Conditions
Cardiopulmonary Bypass
Interventions
DEVICE

CytoSorb

CytoSorb is a first-in-class extracorporeal cytokine adsorber, now approved in the European Union, and broadly indicated for use in any clinical situation where cytokines are elevated.

DRUG

Methylprednisolone

Trial Locations (1)

1000

University Medical Center, Ljubljana

All Listed Sponsors
collaborator

Slovenian Research Agency

OTHER

lead

University Medical Centre Ljubljana

OTHER

NCT02666703 - Extracorporeal Cytokine Adsorption in Cardiac Surgery | Biotech Hunter | Biotech Hunter